AM

Anita Manish Rai

Active Director Director DIN 09449012
DIN 09449012 First appointment Dec 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value •••• Premium profile

About Anita Manish Rai

Data last updated:

Anita Manish Rai is a Director at Rewatrik Lifesciences Private Limited (since 2021). The company operates in Trading. Rewatrik Lifesciences Private Limited reported revenue of ₹44.5 Lakh (FY 2025).

DIN 09449012
Primary Designation Director
Industry Trading
First Appointment 27 Dec 2021
Oldest Company Age 9 yrs
Largest company Rewatrik Lifesciences Private Limited · ₹44.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Dec 20212017₹44.5 Lakh (FY 2025)Active

Board colleagues of Anita Manish Rai

Directorship timeline

Open interactive timeline →
Rewatrik Lifesciences Private Limited
Premium access

Shareholding and investment profile for Anita Manish Rai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Manish Rai

Anita Manish Rai currently holds 1 directorship: Rewatrik Lifesciences Private Limited (Director, since 27 Dec 2021, revenue ₹44.5 Lakh (FY 2025)).

Anita Manish Rai was first appointed on 27 Dec 2021 as Director at Rewatrik Lifesciences Private Limited.

The current boards of Anita Manish Rai's companies include Aric Jaiswal (Rewatrik Lifesciences Private Limited), Pranav Kumar Tyagi (Rewatrik Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available